2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 130 filers reported holding 2SEVENTY BIO INC in Q2 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $102,445 | -55.2% | 26,134 | +15.7% | 0.00% | – |
Q2 2023 | $228,682 | -14.0% | 22,597 | -13.4% | 0.00% | – |
Q1 2023 | $266,006 | +52.9% | 26,079 | +40.5% | 0.00% | – |
Q4 2022 | $173,973 | -81.7% | 18,567 | -71.5% | 0.00% | -100.0% |
Q3 2022 | $949,000 | +3.5% | 65,185 | -6.2% | 0.00% | 0.0% |
Q2 2022 | $917,000 | +280.5% | 69,508 | +391.5% | 0.00% | – |
Q1 2022 | $241,000 | -77.3% | 14,142 | -65.9% | 0.00% | – |
Q4 2021 | $1,061,000 | – | 41,430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 819,672 | $10,820,000 | 4.13% |
Madison Avenue Partners, LP | 1,511,300 | $19,949,000 | 4.08% |
Newtyn Management, LLC | 1,346,796 | $17,778,000 | 3.37% |
Bain Capital Life Sciences Investors, LLC | 1,408,901 | $18,597,000 | 2.18% |
EcoR1 Capital, LLC | 3,495,943 | $46,146,000 | 1.59% |
Casdin Capital, LLC | 614,754 | $8,115,000 | 0.69% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $3,960,000 | 0.60% |
Birchview Capital, LP | 59,833 | $790,000 | 0.58% |
CAAS CAPITAL MANAGEMENT LP | 699,136 | $9,229,000 | 0.46% |
Altium Capital Management LP | 83,000 | $1,096,000 | 0.44% |